Genetic determinants of disease progression in Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 43, Issue 2, 2015, Pages 649-655

  Wang, Xingbin ^a   Lopez, Oscar L ^b   Sweet, Robert A ^b,d   Becker, James T ^b   Dekosky, Steven T ^c   Barmada, Mahmud M ^a   Demirci, F Yesim ^a   Kamboh, M Ilyas ^a,b  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease progression; genome wide association studies; late onset Alzheimer's disease; Mini Mental State Examination

Indexed keywords

APOLIPOPROTEIN E4; CHOLINESTERASE INHIBITOR; EPHRIN RECEPTOR A1; MEMANTINE; TRANSCRIPTION FACTOR PAX3; ADAM PROTEIN; ADAM19 PROTEIN, HUMAN; MEMBRANE PROTEIN; NOCTURNIN; NUCLEAR PROTEIN; PAIRED BOX TRANSCRIPTION FACTOR; PAX3 PROTEIN, HUMAN; PIGQ PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ADAM19 GENE; AGED; ALZHEIMER DISEASE; ARTICLE; CASS4 GENE; CCRN4L GENE; DEMENTIA; DISEASE COURSE; DRUG USE; FEMALE; FERMT2 GENE; GENE; GENETIC ASSOCIATION; GENETIC RISK; HEREDITY; HUMAN; HYPERTENSION; INPP5D GENE; MAJOR CLINICAL STUDY; MALE; MEF2C GENE; MINI MENTAL STATE EXAMINATION; PATIENT CODING; PIGQ GENE; PSYCHOSIS; PTK2B GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TREM2 GENE; GENETIC PREDISPOSITION; GENETICS; MENTAL HEALTH; PATHOPHYSIOLOGY; VERY ELDERLY;

ADAM PROTEINS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; DISEASE PROGRESSION; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MEMBRANE PROTEINS; MENTAL STATUS SCHEDULE; NUCLEAR PROTEINS; PAIRED BOX TRANSCRIPTION FACTORS; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSCRIPTION FACTORS;

EID: 84911865474     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-140729     Document Type: Article

References (37)

1. Evans DA, Funkenstein HH, Albert MS, Scherr PA, Cook NR, Chown MJ, Hebert LE, Hennekens CH, Taylor JO (1989) Prevalence of Alzheimer's disease in a community populationof older persons. Higher than previously reported. JAMA 262, 2551-2556.
2. Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, JonesE (2011) Alzheimer's disease. Lancet 377, 1019-1031.
3. Gatz M, Reynolds CA, Fratiglioni L, Johansson B, Mortimer JA, Berg S, Fiske A, Pedersen NL (2006) Role of genes andenvironments for explaining Alzheimer disease. Arch GenPsychiatry 63, 168-174.
4. Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O, Zelenika D, Bullido MJ, Tavernier B, Letenneur L, Bettens K, Berr C, Pasquier F, Fievet N, Barberger-Gateau P, Engelborghs S, De Deyn P, Mateo I, Franck A, Helisalmi S, Porcellini E, Hanon O, de Pancorbo MM, Lendon C, Dufouil C, Jaillard C, Leveillard T, Alvarez V, Bosco P, Mancuso M, Panza F, Nacmias B, Bossu P, Piccardi P, Annoni G, Seripa D, Galimberti D, Hannequin D, Licastro F, Soininen H, Ritchie K, Blanche H, Dartigues JF, Tzourio C, Gut I, Van Broeckhoven C, Alperovitch A, Lathrop M, Amouyel P (2009) Genome-wide association study identifiesvariants at CLU and CR1 associated with Alzheimer'sdisease. Nat Genet 41, 1094-1099.
5. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Love S, Kehoe PG, Hardy J, Mead S, Fox N, Rossor M, Collinge J, Maier W, Jessen F, Schurmann B, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frolich L, Hampel H, Hull M, Rujescu D, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K, Engelborghs S, De Deyn PP, VanBroeckhoven C, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Muhleisen TW, Nothen MM, Moebus S, Jockel KH, Klopp N, Wichmann HE, Carrasquillo MM, Pankratz VS, Younkin SG, Holmans PA, O'Donovan M, Owen MJ, Williams J (2009) Genome-wide associationstudy identifies variants at CLU and PICALM associated withAlzheimer's disease. Nat Genet 41, 1088-1093.
6. Seshadri S, Fitzpatrick AL, Ikram MA, DeStefano AL, Gudnason V, Boada M, Bis JC, Smith AV, Carassquillo MM, Lambert JC, Harold D, Schrijvers EM, Ramirez-Lorca R, Debette S, Longstreth WT Jr, Janssens AC, Pankratz VS, Dartigues JF, Hollingworth P, Aspelund T, Hernandez I, Beiser A, Kuller LH, Koudstaal PJ, Dickson DW, Tzourio C, Abraham R, Antunez C, Du Y, Rotter JI, Aulchenko YS, Harris TB, Petersen RC, Berr C, Owen MJ, Lopez-Arrieta J, Varadarajan BN, Becker JT, Rivadeneira F, Nalls MA, Graff-Radford NR, Campion D, Auerbach S, Rice K, Hofman A, Jonsson PV, Schmidt H, Lathrop M, Mosley TH, Au R, Psaty BM, Uitterlinden AG, Farrer LA, Lumley T, Ruiz A, Williams J, Amouyel P, Younkin SG, Wolf PA, Launer LJ, Lopez OL, van Duijn CM, Breteler MM (2010) Genome-wide analysisof genetic loci associated with Alzheimer disease. JAMA 303, 1832-1840.
7. Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM, Abraham R, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Jones N, Stretton A, Thomas C, Richards A, Ivanov D, Widdowson C, Chapman J, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Beaumont H, Warden D, Wilcock G, Love S, Kehoe PG, Hooper NM, Vardy ER, Hardy J, Mead S, Fox NC, Rossor M, Collinge J, Maier W, Jessen F, Ruther E, Schurmann B, Heun R, Kolsch H, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frolich L, Hampel H, Gallacher J, Hull M, Rujescu D, Giegling I, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K, Engelborghs S, De Deyn PP, Van Broeckhoven C, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Muhleisen TW, Nothen MM, Moebus S, Jockel KH, Klopp N, Wichmann HE, Pankratz VS, Sando SB, Aasly JO, Barcikowska M, Wszolek ZK, Dickson DW, Graff-Radford NR, Petersen RC, van Duijn CM, Breteler MM, Ikram MA, DeStefano AL, Fitzpatrick AL, Lopez O, Launer LJ, Seshadri S, Berr C, Campion D, Epelbaum J, Dartigues JF, Tzourio C, Alperovitch A, Lathrop M, Feulner TM, Friedrich P, Riehle C, Krawczak M, Schreiber S, Mayhaus M, Nicolhaus S, Wagenpfeil S, Steinberg S, Stefansson H, Stefansson K, Snaedal J, Bjornsson S, Jonsson PV, Chouraki V, Genier-Boley B, Hiltunen M, Soininen H, Combarros O, Zelenika D, Delepine M, Bullido MJ, Pasquier F, Mateo I, Frank-Garcia A, Porcellini E, Hanon O, Coto E, Alvarez V, Bosco P, Siciliano G, Mancuso M, Panza F, Solfrizzi V, Nacmias B, Sorbi S, Bossu P, Piccardi P, Arosio B, Annoni G, Seripa D, Pilotto A, Scarpini E, Galimberti D, Brice A, Hannequin D, Licastro F, Jones L, Holmans PA, Jonsson T, Riemenschneider M, Morgan K, Younkin SG, Owen MJ, O'Donovan M, Amouyel P, Williams J (2011) Commonvariants at ABCA7, MS4A6A/MS4A4 E, EPHA1, CD33 andCD2AP are associated with Alzheimer's disease. Nat Genet43, 429-435.
8. Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J, Gallins PJ, Buxbaum JD, Jarvik GP, Crane PK, Larson EB, Bird TD, Boeve BF, Graff-Radford NR, De Jager PL, Evans D, Schneider JA, Carrasquillo MM, Ertekin-Taner N, Younkin SG, Cruchaga C, Kauwe JS, Nowotny P, Kramer P, Hardy J, Huentelman MJ, Myers AJ, Barmada MM, Demirci FY, Baldwin CT, Green RC, Rogaeva E, St George-Hyslop P, Arnold SE, Barber R, Beach T, Bigio EH, Bowen JD, Boxer A, Burke JR, Cairns NJ, Carlson CS, Carney RM, Carroll SL, Chui HC, Clark DG, Corneveaux J, Cotman CW, Cummings JL, DeCarli C, DeKosky ST, Diaz-Arrastia R, Dick M, Dickson DW, Ellis WG, Faber KM, Fallon KB, Farlow MR, Ferris S, Frosch MP, Galasko DR, Ganguli M, Gearing M, Geschwind DH, Ghetti B, Gilbert JR, Gilman S, Giordani B, Glass JD, Growdon JH, Hamilton RL, Harrell LE, Head E, Honig LS, Hulette CM, Hyman BT, Jicha GA, Jin LW, Johnson N, Karlawish J, Karydas A, Kaye JA, Kim R, Koo EH, Kowall NW, Lah JJ, Levey AI, Lieberman AP, Lopez OL, Mack WJ, Marson DC, Martiniuk F, Mash DC, Masliah E, McCormick WC, McCurry SM, McDavid AN, McKee AC, Mesulam M, Miller BL, Miller CA, Miller JW, Parisi JE, Perl DP, Peskind E, Petersen RC, Poon WW, Quinn JF, Rajbhandary RA, Raskind M, Reisberg B, Ringman JM, Roberson ED, Rosenberg RN, Sano M, Schneider LS, Seeley W, Shelanski ML, Slifer MA, Smith CD, Sonnen JA, Spina S, Stern RA, Tanzi RE, Trojanowski JQ, Troncoso JC, Van Deerlin VM, Vinters HV, Vonsattel JP, Weintraub S, Welsh-Bohmer KA, Williamson J, Woltjer RL, Cantwell LB, Dombroski BA, Beekly D, Lunetta KL, Martin ER, Kamboh MI, Saykin AJ, Reiman EM, Bennett DA, Morris JC, Montine TJ, Goate AM, Blacker D, Tsuang DW, Hakonarson H, Kukull WA, Foroud TM, Haines JL, Mayeux R, Pericak-Vance MA, Farrer LA, Schellenberg GD (2011) Commonvariants at MS4A4/MS4A6 E, CD2 AP, CD33 and EPHA1 areassociated with late-onset Alzheimer's disease. Nat Genet 43, 436-441.
9. Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, Jun G, Destefano AL, Bis JC, Beecham GW, Grenier-Boley B, Russo G, Thornton-Wells TA, Jones N, Smith AV, Chouraki V, Thomas C, Ikram MA, Zelenika D, Vardarajan BN, Kamatani Y, Lin CF, Gerrish A, Schmidt H, Kunkle B, Dunstan ML, Ruiz A, Bihoreau MT, Choi SH, Reitz C, Pasquier F, Hollingworth P, Ramirez A, Hanon O, Fitzpatrick AL, Buxbaum JD, Campion D, Crane PK, Baldwin C, Becker T, Gudnason V, Cruchaga C, Craig D, Amin N, Berr C, Lopez OL, De Jager PL, Deramecourt V, Johnston JA, Evans D, Lovestone S, Letenneur L, Moron FJ, Rubinsztein DC, Eiriksdottir G, Sleegers K, Goate AM, Fievet N, Huentelman MJ, Gill M, Brown K, Kamboh MI, Keller L, Barberger-Gateau P, McGuinness B, Larson EB, Green R, Myers AJ, Dufouil C, Todd S, Wallon D, Love S, Rogaeva E, Gallacher J, St George-Hyslop P, Clarimon J, Lleo A, Bayer A, Tsuang DW, Yu L, Tsolaki M, Bossu P, Spalletta G, Proitsi P, Collinge J, Sorbi S, Sanchez-Garcia F, Fox NC, Hardy J, Naranjo MC, Bosco P, Clarke R, Brayne C, Galimberti D, Mancuso M, Matthews F, Moebus S, Mecocci P, DelZompo M, Maier W, Hampel H, Pilotto A, Bullido M, Panza F, Caffarra P, Nacmias B, Gilbert JR, Mayhaus M, Lannfelt L, Hakonarson H, Pichler S, Carrasquillo MM, Ingelsson M, Beekly D, Alvarez V, Zou F, Valladares O, Younkin SG, Coto E, Hamilton-Nelson KL, Gu W, Razquin C, Pastor P, Mateo I, Owen MJ, Faber KM, Jonsson PV, Combarros O, O'Donovan MC, Cantwell LB, Soininen H, Blacker D, Mead S, Mosley TH, Jr. , Bennett DA, Harris TB, Fratiglioni L, Holmes C, deBruijn RF, Passmore P, Montine TJ, Bettens K, Rotter JI, Brice A, Morgan K, Foroud TM, Kukull WA, Hannequin D, Powell JF, Nalls MA, Ritchie K, Lunetta KL, Kauwe JS, Boerwinkle E, Riemenschneider M, Boada M, Hiltunen M, Martin ER, Schmidt R, Rujescu D, Wang LS, Dartigues JF, Mayeux R, Tzourio C, Hofman A, Nothen MM, Graff C, Psaty BM, Jones L, Haines JL, Holmans PA, Lathrop M, Pericak-Vance MA, Launer LJ, Farrer LA, van Duijn CM, Van Broeckhoven C, Moskvina V, Seshadri S, Williams J, Schellenberg GD, Amouyel P (2013) Meta-analysis of 74, 046 individuals identifies11 new susceptibility loci for Alzheimer's disease. NatGenet 45, 1452-1458.
10. Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, Cruchaga C, Sassi C, Kauwe JS, Younkin S, Hazrati L, Collinge J, Pocock J, Lashley T, Williams J, Lambert JC, Amouyel P, Goate A, Rademakers R, Morgan K, Powell J, St George-Hyslop P, Singleton A, Hardy J (2013) TREM2 variants in Alzheimer's disease. N Engl J Med 368, 117-127.
11. Thalhauser CJ, Komarova NL (2012) Alzheimer's disease:Rapid and slow progression. J R Soc Interface 9, 119-126.
12. Jack CR Jr, Shiung MM, Gunter JL, O'Brien PC, Weigand SD, Knopman DS, Boeve BF, Ivnik RJ, Smith GE, Cha RH, Tangalos EG, Petersen RC (2004) Comparison of different MRIbrain atrophy rate measures with clinical disease progressionin AD. Neurology 62, 591-600.
13. Ridha BH, Barnes J, Bartlett JW, Godbolt A, Pepple T, Rossor MN, Fox NC (2006) Tracking atrophy progression in familial Alzheimer's disease: A serial MRI study. Lancet Neurol 5, 828-834.
14. Sluimer JD, Vrenken H, Blankenstein MA, Fox NC, Scheltens P, Barkhof F, van der Flier WM (2008) Whole-brain atrophyrate in Alzheimer disease: Identifying fast progressors. Neurology 70, 1836-1841.
15. McEvoy LK, Fennema-Notestine C, Roddey JC, Hagler DJ Jr, Holland D, Karow DS, Pung CJ, Brewer JB, Dale AM (2009) Alzheimer disease: Quantitative structural neuroimaging fordetection and prediction of clinical and structural changes inmild cognitive impairment. Radiology 251, 195-205.
16. Nestor SM, Rupsingh R, Borrie M, Smith M, Accomazzi V, Wells JL, Fogarty J, Bartha R (2008) Ventricular enlargementas a possible measure of Alzheimer's disease progression validatedusing the Alzheimer's disease neuroimaging initiativedatabase. Brain 131, 2443-2454.
17. Mann UM, Mohr E, Gearing M, Chase TN (1992) Heterogeneityin Alzheimer's disease: Progression rate segregated bydistinct neuropsychological and cerebral metabolic profiles. J Neurol Neurosurg Psychiatry 55, 956-959.
18. Mielke MM, Rosenberg PB, Tschanz J, Cook L, Corcoran C, Hayden KM, Norton M, Rabins PV, Green RC, Welsh-Bohmer KA, Breitner JC, Munger R, Lyketsos CG (2007) Vascular factors predict rate of progression in Alzheimer disease. Neurology 69, 1850-1858.
19. Prolo P, Chiappelli F, Angeli A, Dovio A, Perotti P, Pautasso M, Sartori ML, Saba L, Mussino S, Fraccalini T, Fanto F, Mocellini C, Rosso MG, Grasso E (2007) Physiologic modulationof natural killer cell activity as an index of Alzheimer'sdisease progression. Bioinformation 1, 363-366.
20. Farrer LA, Cupples LA, van Duijn CM, Connor-Lacke L, Kiely DK, Growdon JH (1995) Rate of progression of Alzheimer's disease is associated with genetic risk. Arch Neurol52, 918-923.
21. Murphy GM, Jr. , Claassen JD, DeVoss JJ, Pascoe N, Taylor J, Tinklenberg JR, Yesavage JA (2001) Rate of cognitive declinein AD is accelerated by the interleukin-1 alpha-889 ∗1 allele. Neurology 56, 1595-1597.
22. Lopez OL, Becker JT, Saxton J, Sweet RA, Klunk W, DeKosky ST (2005) Alteration of a clinically meaningfuloutcome in the natural history of Alzheimer's disease bycholinesterase inhibition. J Am Geriatr Soc 53, 83-87.
23. Kamboh MI, Barmada MM, Demirci FY, Minster RL, Carrasquillo MM, Pankratz VS, Younkin SG, Saykin AJ, Sweet RA, Feingold E, DeKosky ST, Lopez OL (2012) Genomewideassociation analysis of age-at-onset in Alzheimer'sdisease. Mol Psychiatry 17, 1340-1346.
24. Kamboh MI, Demirci FY, Wang X, Minster RL, Carrasquillo MM, Pankratz VS, Younkin SG, Saykin AJ, Jun G, Baldwin C, Logue MW, Buros J, Farrer L, Pericak-Vance MA, Haines JL, Sweet RA, Ganguli M, Feingold E, Dekosky ST, Lopez OL, Barmada MM (2012) Genome-wide association study of Alzheimer's disease. Transl Psychiatry 2, e117.
25. Kamboh MI, Aston CE, Hamman RF (1995) The relationshipof APOE polymorphism and cholesterol levels in normoglycemicand diabetic subjects in a biethnic population fromthe San Luis Valley, Colorado. Atherosclerosis 112, 145-159.
26. Liu JZ, McRae AF, Nyholt DR, Medland SE, Wray NR, Brown KM, Hayward NK, Montgomery GW, Visscher PM, Martin NG, Macgregor S (2010) A versatile gene-based testfor genome-wide association studies. Am J Hum Genet 87, 139-145.
27. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview:Analysis and visualization of LD and haplotype maps. Bioinformatics21, 263-265.
28. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC (2007) PLINK: A tool set for whole-genome associationand population-based linkage analyses. Am J Hum Genet 81, 559-575.
29. Ruiz A, Hernandez I, Ronsende-Roca M, Gonzalez-Perez A, Rodriguez-Noriega E, Ramirez-Lorca R, Mauleon A, Moreno-Rey C, Boswell L, Tune L, Valero S, Alegret M, Gayan J, Becker JT, Real LM, Tarraga L, Ballard C, Terrin M, Sherman S, Payami H, Lopez OL, Mintzer JE, BoadaM (2013) Exploratory analysis of seven Alzheimer's diseasegenes: Disease progression. Neurobiol Aging 34, 1310 e1311-1317.
30. Fang WH, Wang Q, Li HM, Ahmed M, Kumar P, KumarS (2014) PAX3 in neuroblastoma: Oncogenic potential, chemosensitivity and signalling pathways. J Cell Mol Med18, 38-48.
31. Baldwin CT, Hoth CF, Macina RA, Milunsky A (1995) Mutationsin PAX3 that cause Waardenburg syndrome type I: Tennew mutations and review of the literature. Am J Med Genet58, 115-122.
32. Baldwin CT, Lipsky NR, Hoth CF, Cohen T, Mamuya W, Milunsky A (1994) Mutations in PAX3 associated with Waardenburgsyndrome type I. Hum Mutat 3, 205-211.
33. Hoth CF, Milunsky A, Lipsky N, Sheffer R, Clarren SK, Baldwin CT (1993) Mutations in the paired domain of the humanPAX3 gene cause Klein-Waardenburg syndrome (WS-III) aswell as Waardenburg syndrome type I (WS-I) . Am J HumGenet 52, 455-462.
34. Rosenthal SL, Barmada MM, Wang X, Demirci FY, KambohMI (2014) Connecting the dots: Potential of data integrationto identify regulatory SNPs in late-onset Alzheimer's diseaseGWAS findings. PLoS One 9, e95152.
35. Dupressoir A, Barbot W, Loireau MP, Heidmann T (1999) Characterization of a mammalian gene related to the yeastCCR4 general transcription factor and revealed by transposoninsertion. J Biol Chem 274, 31068-31075.
36. Chang YC, Chiu YF, Liu PH, Hee SW, Chang TJ, Jiang YD, Lee WJ, Lee PC, Kao HY, Hwang JJ, Chuang LM (2013) Genetic variation in the NOC gene is associated with bodymass index in Chinese subjects. PLoS One 8, e69622.
37. Ng EL, Tang BL (2008) Rab GTPases and their roles in brainneurons and glia. Brain Res Rev 58, 236-246.